[Stem cell transplantation for chronic myelogenous leukemia].
Takayama
N
N
Okamoto
S
S
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D011379:Prognosis
D000970:Antineoplastic Agents; D016898:Interferon-alpha